AlphAIAlphAI — Financial news for AI agents
pulse2.comOCT 112 min read$NEOG

Neogen: Q1 Revenue Rises 6.5% To $222.8 Million As Company Raises Fiscal 2027 Guidance

Neogen reported Q1 fiscal 2027 revenue of $222.8M, up 6.5%, with Food Safety and Animal Safety segments growing 7.4% and 4.2%, respectively. Gross margin improved to 47.4%. Adjusted net income rose to $17.5M. The company raised its fiscal 2027 revenue guidance to $885M-$890M and adjusted EBITDA guidance to $181M-$183M.

Original reporting
pulse2.com
Published Oct 11, 2026, 9:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 11, 2026, 10:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Neogen: Q1 Revenue Rises 6.5% To $222.8 Million As Company Raises Fiscal 2027 Guidance — source image
Source · pulse2.com
Decision brief

The 30-second read

$NEOGBullishMed
01

Why it matters

The earnings beat and guidance lift suggest stronger demand and operational improvements, which could attract growth‑oriented investors.

02

Market read

Neogen's Q1 results and raised FY guidance provide a clear catalyst for short‑term price movement, with upside potential if execution proceeds as outlined.

03

What to watch

Potential regulatory delays for the Zoetis Genomics sale and the success of the Hinalea Imaging partnership could affect future performance.

Relevance 7/10Novelty 7/10Timing: post‑market today

Background

Neogen is a provider of food safety, animal health, and diagnostic solutions. The company is transitioning to new manufacturing capacity and expanding its product portfolio.

Company-level read

Ticker impact

$NEOGBullishHigh confidence
Context

Neogen posted Q1 revenue up 6.5% and raised FY2027 revenue guidance to $885‑$890M, providing fresh earnings and guidance data.

Expected impact

likely upward pressure as investors price in higher revenue and EBITDA outlook

Evidence & confidence

Revenue and EBITDA guidance were increased, margins improved, and the company announced progress on product launches, all of which are bullish signals.

Market effects

Sector

Food safety and animal health segments see modest growth, supporting peers in the ag‑tech space.

Regional

U.S. biotech and specialty chemicals markets may see slight uplift from Neogen's guidance beat.

Global

Limited to niche food safety sector; broader market impact minimal.

Counterpoint

What could challenge this read

Guidance raise may already be priced in; execution risk on new Petrifilm line could temper upside.

Key entities

  • company
    Neogen Corp

    Provider of food safety and animal health diagnostics.

  • company
    Zoetis

    Potential buyer of Neogen's global Genomics business.

Read at source← All news

StoryNeogen reports Q1 FY2027 revenue growth and raises FY2027 guidance

Also covered by

2 outlets

Related articles

OCT 8
$NEOGMedAI 8/10

Neogen’s Earnings Call Signals Confident Growth Path

Neogen reported Q1 revenue of $222.8M, up 8.1% core, with Food Safety and Animal Safety segments driving growth. Management raised fiscal 2027 guidance to $885M-$890M sales and adjusted EBITDA of $181M-$183M, citing strong demand and operational improvements. The company plans to use genomics divestiture proceeds for debt reduction, aiming for net leverage below 3x.

tipranks.com3 min
OCT 7
$NEOGLow

Neogen Outlines Strategy for Growth, Innovation and Margin Expan

Neogen Corporation (NEOG) outlined its growth strategy at its 2026 Investor Day, targeting high-single-digit to low-double-digit revenue growth, high-50% adjusted gross margin, and 30% adjusted EBITDA margin by FY2031. The company plans to increase R&D investment by 50% in FY2027, aiming for $100M in incremental revenue from new products by FY2031. Neogen also highlighted its data platform, Neogen Analytics, as a key driver of recurring revenue and customer retention.

gurufocus.com3 min
OCT 7
$NEOGHighAI 8/10

Why Are Neogen (NEOG) Shares Soaring Today

Neogen (NEOG) shares rose 14.1% premarket after Q3 2026 results beat expectations, with revenue up 6.5% YoY to $222.8M. The company raised full-year guidance, citing strong growth in indicator testing and Petrifilm. Shares later cooled to $11.79, down 1.7% from the previous close.

finance.yahoo.com2 min
OCT 7
$NEOGMed

Neogen (NEOG) Q1 2027 Earnings Call Transcript

Neogen (NEOG) reported Q1 2027 revenue of $222.8M, up 8.1% year-over-year, driven by commercial excellence. Food Safety segment revenue was $163.2M, with 8.1% core growth. The company is investing in innovation, technology, and operational efficiency to drive long-term growth and margin expansion. Key initiatives include commercial prowess, high-impact innovation, and operational excellence.

finance.yahoo.com3 min